1,030 filings
Page 4 of 52
4
James V Caruso
18 Jan 23
Cellectar Biosciences / JAMES V CARUSO ownership change
6:34pm
4
Chad J Kolean
18 Jan 23
Cellectar Biosciences / Chad J Kolean ownership change
6:33pm
8-K
CLRB
Cellectar Biosciences Inc
4 Jan 23
Entry into a Material Definitive Agreement
7:00am
4
Darrell Shane Lea
15 Dec 22
Cellectar Biosciences / Darrell Shane Lea ownership change
5:00pm
3
Darrell Shane Lea
15 Dec 22
Cellectar Biosciences / Darrell Shane Lea ownership change
4:45pm
424B3
CLRB
Cellectar Biosciences Inc
5 Dec 22
Prospectus supplement
7:04am
EFFECT
CLRB
Cellectar Biosciences Inc
5 Dec 22
Notice of effectiveness
12:15am
8-K
CLRB
Cellectar Biosciences Inc
2 Dec 22
Entry into a Material Definitive Agreement
5:23pm
CORRESP
CLRB
Cellectar Biosciences Inc
30 Nov 22
Correspondence with SEC
12:00am
UPLOAD
CLRB
Cellectar Biosciences Inc
29 Nov 22
Letter from SEC
12:00am
S-1
CLRB
Cellectar Biosciences Inc
IPO registration
23 Nov 22
4:20pm
10-Q
2022 Q3
CLRB
Cellectar Biosciences Inc
Quarterly report
3 Nov 22
8:45am
8-K
CLRB
Cellectar Biosciences Inc
3 Nov 22
Cellectar Reports Financial Results for Third Quarter 2022 and Provides a Corporate Update
8:40am
SC 13G/A
Rosalind Advisors, Inc.
3 Nov 22
Cellectar Biosciences / Rosalind Advisors ownership change
12:00am
8-K
CLRB
Cellectar Biosciences Inc
25 Oct 22
Entry into a Material Definitive Agreement
5:03pm
SC 13G
Lincoln Park Capital Fund, LLC
25 Oct 22
Cellectar Biosciences / Lincoln Park Capital Fund ownership change
6:01am
424B5
CLRB
Cellectar Biosciences Inc
24 Oct 22
Prospectus supplement for primary offering
4:36pm
424B5
CLRB
Cellectar Biosciences Inc
20 Oct 22
Prospectus supplement for primary offering
4:37pm
8-K
CLRB
Cellectar Biosciences Inc
22 Sep 22
Cellectar Awarded $2 Million Grant to Expand Its Ongoing Phase 1 Study of Iopofosine I 131 in Pediatric Brain Tumors
8:45am
8-K
CLRB
Cellectar Biosciences Inc
13 Sep 22
Other Events
8:45am